Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304

Diabetic Medicine

Volumn 16, Issue 4, 1999, Pages 332-338

  Heinemann, Lutz ^c   Sinha, K ^d   Weyer, C ^d   Loftager, M ^a   Hirschberger, S ^b   Heise, T ^d  

^a NOVO NORDISK A S   (Denmark)

^b Novo Nordisk Pharma GmbH   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d NONE

Author keywords

Glucose clamp; Insulin; Long acting insulin analogues; Pharmacodynamics; Time action profile

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; ISOPHANE INSULIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL;

ACYLATION; ADULT; CARRIER PROTEINS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; LINEAR MODELS; MALE; REFERENCE VALUES; SOLUBILITY;

EID: 0003852563     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00081.x     Document Type: Article

References (11)

1. 1 Markussen J, Havelund S, Kurtzhals P, Andersen AS, Halstrom J, Hasselager E et al. Soluble, fatty acid atylated insulins bind to albumin and show protracted action in pigs. Diabetologia 1996; 39: 281-288.
2. 2 Markussen J, Andersen AS, Vad K. Synthesis of the soluble, long-acting insulin NN304. Diabetes 1996; 45: 220A.
3. 3 Kurtzhals P, Havelund S, Jonassen I, Ribel U, Markussen J. Mode of action of fatty acid acylated insulin: a novel type of soluble, long-acting insulin analogues. Diabetes 1996; 45: 222A.
4. 4 Hamilton-Wessler M, Ader M, Dea M, Moore D, Markussen J, Bergman RN. Long-acting insulin analog NN304 is transported independent of native insulin. Diabetes 1997; 46: 164A.
5. 5 Hamilton-Wessler M, Ader M, Dea M, Moore D, Markussen J. Long-acting insulin analog NN304 has similar transendothelial transport to porcine insulin. Diabetes 1997; 46: 164A.
6. 6 Myers SR, Yakubu-Madus F, Johnson WT, Baker JE, Cusick T, Williams VK et al. Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs. Diabetes 1997; 46: 637-642.
7. 7 Howey DC, Woodworth JR, Bowsher RR, Reviergo J. Pharmacokinetic and glutodynamic assessments of N-palmitoyl. LYS (B29) human insulin in healthy volunteers. Diabetologia 1997; 40 (Suppl. 1): A354.
8. 8 Radziuk J, Pye S, Bradley BJ, Braaten J, Vignati L, Roach P. Basal activity profiles of NPH and [N-epsilon-palmitoyl Lys(B29)] human insulins in subjects with IDDM. Diabetologia 1998; 41: 116-120.
9. 9 Kurtzhals P. Albumin binding interactions between acylated insulin, fatty acids and selected drugs. Diabetes 1996; 45: 219A.
10. 10 Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Ribel U, Markussen J. Albumin binding and time action of acylated insulins in various species. J Pharm Sci 1996; 85: 304-308.
11. 11 Havelund S, Kurtzhals P, Jonassen I, Ribel U, Markussen J. The time-action profile of acylated insulins depend on the animal model. Diabetologia 1996; 39: A224.